Yong Man Kim
Direttore Tecnico/Scientifico/R&S presso NKMAX Co., Ltd.
Patrimonio netto: 56 200 $ in data 30/04/2024
Profilo
Yong Man Kim is currently the Chief Scientific Officer & Director at NKMAX Co., Ltd., the Director & Chief Scientific Officer at NKGen Biotech, Inc., and the Chief Scientific & Innovation Officer at NKGen Operating Biotech, Inc. He holds a doctorate degree from Chungnam National University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
0.12% | 12/02/2024 | 28 384 ( 0.12% ) | 56 200 $ | 30/04/2024 |
Posizioni attive di Yong Man Kim
| Società | Posizione | Inizio |
|---|---|---|
NKGen Biotech, Inc.
 NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Direttore/Membro del Consiglio | 01/11/2021 |
NKMAX Co., Ltd.
 NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Direttore Tecnico/Scientifico/R&S | 01/09/2017 |
Precedenti posizioni note di Yong Man Kim
| Società | Posizione | Fine |
|---|---|---|
| Wonkwang University | Corporate Officer/Principal | - |
Formazione di Yong Man Kim
| Chungnam National University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
NKMAX Co., Ltd.
NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea. | Health Technology |
NKGen Biotech, Inc.
NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA. | Health Technology |
- Borsa valori
- Insiders
- Yong Man Kim
